Yupo Ma - Stony Brook University Hospital

基本信息

浏览量：76

职业迁徙

个人简介

暂无内容

研究兴趣

论文共 138 篇作者统计合作学者相似作者

按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选

A nontandem novel compound chimeric antigen receptor redirected to target CD20-CD19 positive B-cell acute leukemias and B-cell lymphoma

Vincent M. DeStefano,Masayuki Wada,Kevin G. Pinz,Rita Assi,Hongyu Zhang,Weijia Wang, Wenli Zhang, Darshi Shah,Yupo Ma,Huda Salman

CLINICAL AND TRANSLATIONAL MEDICINEno. 7 (2024): e1743-e1743

引用0浏览0WOS引用

BCMA-CD19 Compound CAR T Cells for Systemic Lupus Erythematosus: a Phase 1 Open-Label Clinical Trial

Weijia Wang,Shanzhi He,Wenli Zhang,Hongyu Zhang,Vincent M. Destefano,Masayuki Wada,Kevin Pinz, Greg Deener, Darshi Shah,Nabil Hagag, Min Wang,Ming Hong, Ronghao Zeng,Ting Lan, Yu Ma,Fugui Li, Yingwen Liang, Zhencong Guo,Chanjuan Zou, Mingxia Wang, Ling Ding,Yupo Ma,Yong Yuan

ANNALS OF THE RHEUMATIC DISEASES (2024)

引用0浏览0WOS引用

Novel BCMA-CD19 Compound CAR-T (ccar) Targets B Cells and Plasma Cells Achieving Immune Reset and Eliminates All Autoantibodies in Systemic Lupus Erythematosus (SLE) and Lupus Nephritis (LN) Patients Resulting in Long-Term, Medication-Free Remission

Yong Yuan, Shanzhi He,Wenli Zhang,Hongyu Zhang,Vincent DeStefano,Masayuki Wada,Kevin Pinz, Greg Deener, Yu Ma, Min Wang,Fugui Li, Ming Hong,Chanjuan Zou, Mingxia Wang, Ling Ding, Yingwen Liang,Yupo Ma,Weijia Wang

ARTHRITIS & RHEUMATOLOGY (2023): 2947-2948

引用0浏览0引用

683 Phase I First-in-human Study on the Feasibility, Safety, and Antitumor Activity of CD4-redirected Chimeric Antigen Receptor (CAR) T-cell Therapy in Patients with CD4+ T-cell Malignancies (TCM)

Rita Assi,Nabil Hagag,Sherif Farag,Robert Emmons, Allie Carter,Magdalena Czader,Rafat Abonnour,Lionel Apetoh,Yupo Ma,Huda Salman

Regular and Young Investigator Award Abstracts (2023)

引用0浏览0引用

A Rare Case of B-lymphoid Blast Phase of Chronic Myeloid Leukemia: Diagnostic Challenges

Nada Naiyer,Ann-Leslie Zaslav,Tahmeena Ahmed,Silvia Spitzer,Yupo Ma, Roxanna Ponce, Htien Lee,Hong Lin

LEUKEMIA RESEARCH REPORTS（2022）

引用0浏览0WOS引用

Treatment of aggressive T-cell lymphoma/leukemia with anti-CD4 CAR T cells

Jia Feng,Haichan Xu,Andrew Cinquina, Zehua Wu,Wenli Zhang,Lihua Sun,Qi Chen,Lei Tian,Le Song,Kevin G. Pinz,Masayuki Wada,Xun Jiang,William M. Hanes,Yupo Ma,Hongyu Zhang

Front Immunol（2022）

引用4浏览0WOS引用

Luteolin and Its Derivative Apigenin Suppress the Inducible PD-L1 Expression to Improve Anti-Tumor Immunity in KRAS-mutant Lung Cancer

Ze-Bo Jiang,Wen-Jun Wang,Cong Xu,Ya-Jia Xie,Xuan-Run Wang,Yi-Zhong Zhang,Ju-Min Huang,Min Huang,Chun Xie,Pei Liu,Xing-Xing Fan,Yu-Po Ma,Pei-Yu Yan,Liang Liu,Xiao-Jun Yao,Qi-Biao Wu,Elaine Lai-Han Leung

Cancer Letters (2021): 36-48

引用124浏览0WOS引用

124

Plumbagin Suppresses Non-Small Cell Lung Cancer Progression Through Downregulating ARF1 and by Elevating CD8+ T Cells

Ze-Bo Jiang,Cong Xu,Wenjun Wang,Yi-Zhong Zhang,Ju-Min Huang,Ya-Jia Xie,Qian-Qian Wang,Xing-Xing Fan,Xiao-Jun Yao,Chun Xie,Xuan-Run Wang,Pei-Yu Yan,Yu-Po Ma,Qi-Biao Wu,Elaine Lai-Han Leung

Pharmacological Research (2021): 105656-105656

引用5浏览0WOS引用

加载更多

作者统计

合作学者

合作机构

D-Core

合作者
学生
导师

暂无相似学者，你可以通过学者研究领域进行搜索筛选

数据免责声明

页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果，我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问，可以通过电子邮件方式联系我们：report@aminer.cn